Accelerate Diagnostics, Inc. (AXDX)

NASDAQ: AXDX · IEX Real-Time Price · USD
0.970
-0.015 (-1.53%)
At close: Mar 1, 2024, 4:00 PM
1.020
+0.050 (5.15%)
After-hours: Mar 1, 2024, 7:35 PM EST
-1.53%
Market Cap 20.66M
Revenue (ttm) 12.00M
Net Income (ttm) -63.23M
Shares Out 20.27M
EPS (ttm) -6.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,767
Open 1.030
Previous Close 0.985
Day's Range 0.953 - 1.080
52-Week Range 0.830 - 11.900
Beta 0.60
Analysts n/a
Price Target n/a
Earnings Date Mar 27, 2024

About AXDX

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic sus... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 18, 1996
Employees 179
Stock Exchange NASDAQ
Ticker Symbol AXDX
Full Company Profile

Financial Performance

In 2022, AXDX's revenue was $12.75 million, an increase of 8.23% compared to the previous year's $11.78 million. Losses were -$62.49 million, -19.57% less than in 2021.

Financial Statements

News

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

TUCSON, Ariz. , Jan. 19, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the "Company") today announced the pricing of an underwritten public offering consisting of 6,860,659 units, ...

6 weeks ago - PRNewsWire

Accelerate Diagnostics Announces Launch of Proposed Public Offering

TUCSON, Ariz. , Jan. 16, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the "Company") today announced the launch of a proposed underwritten public offering of 4,500,000 units, each...

6 weeks ago - PRNewsWire

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results

TUCSON, Ariz. , Jan. 7, 2024 /PRNewswire/ --  Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes an...

2 months ago - PRNewsWire

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

Working together to bring rapid, automated microbial identification directly from positive blood culture samples TUCSON, Ariz. , Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXD...

Other symbols: BRKR
3 months ago - PRNewsWire

Accelerate Diagnostics Reports Third Quarter 2023 Results

TUCSON, Ariz. , Nov. 9, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2023.

4 months ago - PRNewsWire

Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.

TUCSON, Ariz. , Oct. 30, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m.

4 months ago - PRNewsWire

Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

TUCSON, Ariz. , Aug. 10, 2023 /PRNewswire/ --  Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023.

7 months ago - PRNewsWire

Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

TUCSON, Ariz. , July 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m.

7 months ago - PRNewsWire

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

TUCSON, Ariz. , July 10, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it will conduct a...

8 months ago - PRNewsWire

Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave

TUCSON, Ariz. , June 13, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) a leading provider of innovative rapid diagnostic solutions, has closed the transactions contemplated by the ...

9 months ago - PRNewsWire

Accelerate Diagnostics Reports First Quarter 2023 Financial Results

TUCSON, Ariz. , May 11, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023.

10 months ago - PRNewsWire

Accelerate Diagnostics scheduled call to review 2023 first quarter results

TUCSON, Ariz. , April 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, May 11, 2023, at 4:30 p.m.

11 months ago - PRNewsWire

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

TUCSON, Ariz. , March 29, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022.

1 year ago - PRNewsWire

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

TUCSON, Ariz. , March 15, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 29, 2023, at 4:30 p.m.

1 year ago - PRNewsWire

Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement

TUCSON, Ariz. , March 14, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be step...

1 year ago - PRNewsWire

Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors

TUCSON, Ariz. , March 8, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the appointment...

1 year ago - PRNewsWire

Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit

TUCSON, Ariz. , Dec. 19, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that the Company has submitted a 510(k) application to the FDA for Gram-negative menu expansio...

1 year ago - PRNewsWire

Accelerate Diagnostics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - November 15, 2022) - Block & Leviton is investigating Accelerate Diagnostics, Inc. (NASDAQ: AXDX) for potential securities law violations. Investors who have l...

1 year ago - Newsfile Corp

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results

TUCSON, Ariz. , Nov. 14, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter for the period ended September 30, 2022.

1 year ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX

NEW YORK , Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Accelerate Diagnostics, Inc. ("Accelerate" or the "Company") (NASDAQ: AXDX).  Such investors ar...

1 year ago - PRNewsWire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Accelerate Diagno...

1 year ago - Business Wire

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 27, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of A...

1 year ago - Newsfile Corp

The Law Offices of Frank R. Cruz Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R.

1 year ago - Business Wire

Accelerate Diagnostics Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - October 26, 2022) - Block & Leviton is investigating Accelerate Diagnostics, Inc. (NASDAQ: AXDX) for potential securities law violations. Investors who have lo...

1 year ago - Newsfile Corp